SCHEMBL2942267

SCHEMBL2942267

CC1CN(CCC(=O)Nc2cc(CN3C(=O)N(c4ccc(C(F)(F)F)cc4S)C(=O)C3(C)C)ccn2)CC(C)O1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 16/20 0.47
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2941363 0.92 IGF1R (0.48) IGF1R
SCHEMBL2933343 0.89 IGF1R (0.50) IGF1RLMNA
SCHEMBL2938067 0.89 IGF1R (0.50) IGF1R
SCHEMBL2941088 0.89 IGF1R (0.48) IGF1RSMN1; SMN2
SCHEMBL2939573 0.89 IGF1R (0.49) IGF1R
SCHEMBL2940303 0.89 IGF1R (0.46) IGF1RGAASMN1; SMN2
SCHEMBL2939986 0.88 IGF1R (0.49) IGF1R
SCHEMBL2943419 0.84 IGF1R (0.55) IGF1R
SCHEMBL2935797 0.84 IGF1R (0.69) IGF1R
SCHEMBL2936413 0.84 IGF1R (0.45) IGF1RGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed